ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on Twitter

Kidney Week

Clinical Practice Session

Vanguard Medicine: Novel Therapies on the Horizon

October 22, 2020 | 02:30 PM - 04:30 PM

Location: Simulive

Session Description

There are several novel therapies in the pipeline and new indications for approved drugs in the management of glomerular disease, lupus, and obesity. This session reviews mechanisms, risks, and benefits of therapies for several disease processes in CKD.

Learning Objective(s)

  • Discuss real-world use and safety signals for novel therapeutics
  • Outline emerging indications for approved therapies

Learning Pathway(s)

  • Chronic Kidney Disease
  • Acute Kidney Injury


  • Derek M. Fine, MD
  • Melanie P. Hoenig, DrMed, MD


  • New Options for Weight Loss in CKD: Bardoxolone and GLP-1 Agonists
    02:30 PM - 03:00 PM
    Glenn Matthew Chertow, MD, MPH, FASN
  • Emerging Therapies for FSGS
    03:00 PM - 03:30 PM
    Kirk N. Campbell, MD, FASN
  • Emerging Therapies in Lupus
    03:30 PM - 04:00 PM
    Patrick H. Nachman, MD, FASN 
  • New Formulations of Gadolinium: Still Contraindicated in Advanced CKD?
    04:00 PM - 04:30 PM
    Kirsten L. Johansen, MD, FASN